Andrey Mladentsev
Consultant / Advisor chez V12 Venture Israel MC Ltd.
Profil
Healthcare professional.
Former VP CIS & Baltics at Stada, CEO at Promomed, CEO at NizhPharm (acquired by Stada), CEO at OBL Pharm (acquired by AFK Sistema).
Postes actifs de Andrey Mladentsev
| Sociétés | Poste | Début |
|---|---|---|
V12 Venture Israel MC Ltd.
 V12 Venture Israel MC Ltd. Investment ManagersFinance V12 Venture Israel MC Ltd (V12 Venture Israel) is a venture capital firm founded in 2020. The firm is headquartered in Tel Aviv, Israel. | Consultant / Advisor | - |
Anciens postes connus de Andrey Mladentsev
| Sociétés | Poste | Fin |
|---|---|---|
| STADA ARZNEIMITTEL | Private Equity Investor | 01/03/2007 |
Formation de Andrey Mladentsev
| IEDC Bled School of Management | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
V12 Venture Israel MC Ltd.
V12 Venture Israel MC Ltd. Investment ManagersFinance V12 Venture Israel MC Ltd (V12 Venture Israel) is a venture capital firm founded in 2020. The firm is headquartered in Tel Aviv, Israel. | Finance |
STADA Arzneimittel AG
 STADA Arzneimittel AG Pharmaceuticals: MajorHealth Technology STADA Arzneimittel AG engages in the provision of healthcare and pharmaceutical products. It operates through the following segments: Generics, Consumer Healthcare, and Specialty. The Generics segment produces and distributes generic drugs. The Consumer Healthcare segment includes products such as OTC drugs, nutritional supplements and certain consumer healthcare products such as disinfectants and sunscreen. The Specialty segment includes branded generics, specialty generics, and biosimilars. Its brands include Zoflora, Grippostad, Nizoral, and Shampoo & Ladival. The company was founded on March 14, 1895 and is headquartered in Bad Vilbel, Germany. | Health Technology |
